207 related articles for article (PubMed ID: 24004587)
41. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
Yamada Y; Kohashi K; Fushimi F; Takahashi Y; Setsu N; Endo M; Yamamoto H; Tokunaga S; Iwamoto Y; Oda Y
Cancer; 2014 Mar; 120(6):864-76. PubMed ID: 24353015
[TBL] [Abstract][Full Text] [Related]
42. Adenosine kinase expression in cortical dysplasia with balloon cells: analysis of developmental lineage of cell types.
Luan G; Gao Q; Zhai F; Zhou J; Liu C; Chen Y; Li T
J Neuropathol Exp Neurol; 2015 Feb; 74(2):132-47. PubMed ID: 25575137
[TBL] [Abstract][Full Text] [Related]
43. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
44. Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.
Arai A; Saito T; Hanai S; Sukigara S; Nabatame S; Otsuki T; Nakagawa E; Takahashi A; Kaneko Y; Kaido T; Saito Y; Sugai K; Sasaki M; Goto Y; Itoh M
Brain Res; 2012 Aug; 1470():89-97. PubMed ID: 22759905
[TBL] [Abstract][Full Text] [Related]
45. Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
Mühlebner A; Coras R; Kobow K; Feucht M; Czech T; Stefan H; Weigel D; Buchfelder M; Holthausen H; Pieper T; Kudernatsch M; Blümcke I
Acta Neuropathol; 2012 Feb; 123(2):259-72. PubMed ID: 22120580
[TBL] [Abstract][Full Text] [Related]
46. Glutamate clearance mechanisms in resected cortical dysplasia.
González-Martínez JA; Ying Z; Prayson R; Bingaman W; Najm I
J Neurosurg; 2011 Apr; 114(4):1195-202. PubMed ID: 21073256
[TBL] [Abstract][Full Text] [Related]
47. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.
Buccoliero AM; Caporalini C; Giordano F; Mussa F; Scagnet M; Moscardi S; Baroni G; Genitori L; Taddei GL
Clin Neuropathol; 2016; 35(5):295-301. PubMed ID: 27390104
[TBL] [Abstract][Full Text] [Related]
48. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
49. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
50. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
[TBL] [Abstract][Full Text] [Related]
51. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
[TBL] [Abstract][Full Text] [Related]
52. Aberrant adenosine signaling in patients with focal cortical dysplasia.
Guo M; Zhang J; Wang J; Wang X; Gao Q; Tang C; Deng J; Xiong Z; Kong X; Guan Y; Zhou J; Boison D; Luan G; Li T
Mol Neurobiol; 2023 Aug; 60(8):4396-4417. PubMed ID: 37103687
[TBL] [Abstract][Full Text] [Related]
53. Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.
Leventer RJ; Scerri T; Marsh AP; Pope K; Gillies G; Maixner W; MacGregor D; Harvey AS; Delatycki MB; Amor DJ; Crino P; Bahlo M; Lockhart PJ
Neurology; 2015 May; 84(20):2029-32. PubMed ID: 25878179
[TBL] [Abstract][Full Text] [Related]
54. Abnormal maturation of non-dysmorphic neurons in focal cortical dysplasia: immunohistochemical considerations.
Hanai S; Saito T; Nakagawa E; Arai A; Otsuki T; Sasaki M; Goto Y; Itoh M
Seizure; 2010 Jun; 19(5):274-9. PubMed ID: 20452788
[TBL] [Abstract][Full Text] [Related]
55. KCC2 was downregulated in small neurons localized in epileptogenic human focal cortical dysplasia.
Shimizu-Okabe C; Tanaka M; Matsuda K; Mihara T; Okabe A; Sato K; Inoue Y; Fujiwara T; Yagi K; Fukuda A
Epilepsy Res; 2011 Feb; 93(2-3):177-84. PubMed ID: 21256718
[TBL] [Abstract][Full Text] [Related]
56. Expression patterns of AMOG in developing human cortex and malformations of cortical development.
Boer K; Spliet WG; van Rijen PC; Jansen FE; Aronica E
Epilepsy Res; 2010 Sep; 91(1):84-93. PubMed ID: 20656459
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
[TBL] [Abstract][Full Text] [Related]
58. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
[TBL] [Abstract][Full Text] [Related]
59. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
[TBL] [Abstract][Full Text] [Related]
60. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
